Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing
Categories
Health Care
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Satish Wagh -- Chairman and Managing Director Saloni Wagh -- Director Krishna
Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript
Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen -- Chairman and Managing Director Alisha Moopen -- Deputy
Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Transcript
Sequent Scientific Limited (NSE:SEQUENT) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Rajaram Narayanan -- Managing Director P.V. Raghavendra
Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q3 FY23 Earnings Concall Transcript
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Suneeta Reddy -- Managing Director Sanjiv Gupta -- CFO Unidentified Speaker --
Biocon Limited (BIOCON) Q3 FY23 Earnings Concall Transcript
Biocon Limited (NSE:BIOCON) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Saurabh Paliwal -- Head - Investor Relations Kiran Mazumdar Shaw -- Biocon Ltd.
Marksans Pharma Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked why there
Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Abhijit Majumdar -- Chief Financial Officer Saharsh Davuluri -- Vice Chairman and
Krsnaa Diagnostics Ltd (KRSNAA) Q3 FY23 Earnings Concall Transcript
Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Pallavi Bhatevara -- Managing Director Pawan Daga -- Chief Financial Officer Yash
Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript
Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive Officer Jitendra
Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY
Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw
Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of
Themis Medicare Ltd (THEMISMED) Q3 FY23 Earnings Concall Transcript
Themis Medicare Ltd (NSE:THEMISMED) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Sachin D. Patel -- Managing Director and Chief Executive Officer
Rainbow Children’s Medicare Ltd (RAINBOW) Q3 FY23 Earnings Concall Transcript
Rainbow Children's Medicare Ltd (NSE:RAINBOW) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director R. Gowrisankar -- Chief
Panacea Biotec Q3FY23; 26% Fall in Revenue
Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in
Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript
Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra -- Senior Vice President, Investor Relations Ashutosh Raghuvanshi -- Managing
Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY23 Earnings Concall Transcript
Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Utkarsh Gandhi -- General Manager, Investor Relations Glenn Saldanha -- Chairman and
Metropolis Healthcare Limited (METROPOLIS) Q3 FY23 Earnings Concall Transcript
Metropolis Healthcare Limited (NSE:METROPOLIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Cyndrella Carvalho -- Vice President - Healthcare/Pharma Lead at JM
Alembic Pharmaceuticals LTD. (NSE: APLLTD): Q3 FY23 Results Out; Total Income Rises 18% YoY
Alembic Pharmaceuticals Ltd. (NSE:APLLTD) is an Indian pharmaceutical company that was founded in 1907. It is headquartered in Vadodara, Gujarat, and operates